GC
Ascentage Pharma makes second attempt at IPO
China’s Ascentage Pharma Group International has refiled a prospectus for its second attempt to list on the Hong Kong Stock Exchange (HKEX).
The biotech company filed a new draft prospectus on Thursday, eight months after its first try. The filing the issuer made for its first attempt expired after six months, something that happened to a number of borrowers last year when dreadful equity markets put paid to various
...
Already a subscriber? Login
